As of 2025-07-05, the Intrinsic Value of Ikena Oncology Inc (IKNA) is -4.51 USD. This IKNA valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.33 USD, the upside of Ikena Oncology Inc is -438.81%.
Based on its market price of 1.33 USD and our intrinsic valuation, Ikena Oncology Inc (IKNA) is overvalued by 438.81%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.51 - -4.51 | -4.51 | -438.81% |
| P/E | (33.09) - (43.69) | (41.37) | -3210.2% |
| DDM - Stable | (7.01) - (18.30) | (12.65) | -1051.4% |
| DDM - Multi | (5.24) - (10.76) | (7.06) | -630.9% |
| Market Cap (mil) | 72.66 |
| Beta | 0.84 |
| Outstanding shares (mil) | 54.63 |
| Enterprise Value (mil) | 35.89 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.72% |
| Cost of Debt | 5.00% |
| WACC | 7.19% |